share_log
Benzinga ·  Mar 26 11:05
As Of December 31, 2024, Precision BioSciences Had Approximately $108.5M In Cash, Cash Equivalents, And Restricted Cash, With Expected Cash Runway Into The Second Half Of 2026
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 343

Recommended

Write a comment